ARVEE LABORATORIES I LTD (ARVEE) financials

ARVEE LABORATORIES I LTD (ARVEE) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 2012, Arvee Laboratories India Ltd manufactures specialized chemicals[1]

Market Cap: ₹249Cr.
Current Price: ₹226
Stock P/E: 61.6
ROE: 7.32%
ROCE: 7.53%
Book Value: ₹30.7
Dividend Yield: 0.00%
52W High / Low: ₹291/129

In Jun 2026, ARVEE LABORATORIES I LTD (ARVEE) reported sales ₹17.23 Cr and net profit ₹1.69 Cr.

Annual TTM: sales ₹41.26 Cr, net profit ₹4.05 Cr.

Shareholding: Promoters 73.50% (Sep 2026), Public 26.50% (Sep 2026), No. of Shareholders 1,947% (Sep 2026).

ARVEE quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	12.53	8.91	6.45	7.48	3.45	9.78	10.80	17.23
Expenses	11.03	8.57	6.23	7.14	3.33	8.15	9.70	14.74
Operating Profit	1.50	0.34	0.22	0.34	0.12	1.63	1.10	2.49
OPM %	11.97%	3.82%	3.41%	4.55%	3.48%	16.67%	10.19%	14.45%
Other Income	0.16	0.19	0.21	0.17	0.23	0.14	0.15	0.18
Interest	0.05	0.05	0.07	0.04	0.04	0.07	0.08	0.06
Depreciation	0.30	0.28	0.27	0.29	0.30	0.30	0.31	0.32
Profit before tax	1.31	0.20	0.09	0.18	0.01	1.40	0.86	2.29
Tax %	25.19%	25.00%	22.22%	5.56%	0.00%	-30.71%	38.37%	26.20%
Net Profit	0.98	0.15	0.07	0.17	0.01	1.83	0.52	1.69
EPS in Rs	0.89	0.14	0.06	0.15	0.01	1.66	0.47	1.53
Raw PDF	—	—	—	—	—	—	—	—

ARVEE profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	45.42	47.38	40.33	61.35	30.35	38.49	31.51	41.26
Expenses	39.40	41.31	34.65	54.06	27.41	34.88	28.33	35.92
Operating Profit	6.02	6.07	5.68	7.29	2.94	3.61	3.18	5.34
OPM %	13.25%	12.81%	14.08%	11.88%	9.69%	9.38%	10.09%	12.94%
Other Income	0.35	0.56	0.46	1.35	0.64	0.66	0.69	0.70
Interest	0.99	0.58	0.37	0.39	0.25	0.25	0.23	0.25
Depreciation	2.29	2.41	2.32	2.08	1.50	1.15	1.21	1.23
Profit before tax	3.09	3.64	3.45	6.17	1.83	2.87	2.43	4.56
Tax %	25.89%	26.37%	25.51%	33.23%	42.62%	25.09%	-3.70%	—
Net Profit	2.30	2.68	2.57	4.12	1.05	2.15	2.53	4.05
EPS in Rs	2.09	2.43	2.33	3.74	0.95	1.95	2.30	3.67
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

ARVEE balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	5.51	5.51	11.02	11.02	11.02	11.02	11.02	11.02
Reserves	10.95	13.25	10.42	12.92	17.04	18.09	20.24	22.77
Borrowings	12.87	3.87	8.88	3.13	1.00	1.00	1.03	1.11
Other Liabilities	7.81	11.00	10.73	11.61	9.63	8.45	5.29	7.99
Total Liabilities	37.14	33.63	41.05	38.68	38.69	38.56	37.58	42.89
Fixed Assets	12.65	13.18	13.81	13.84	12.68	12.67	15.27	16.72
CWIP	2.32	1.78	0.97	0.98	1.53	2.62	0.73	0.90
Investments	1.95	3.09	2.03	0.00	0.00	0.00	0.00	1.70
Other Assets	20.22	15.58	24.24	23.86	24.48	23.27	21.58	23.57
Total Assets	37.14	33.63	41.05	38.68	38.69	38.56	37.58	42.89

ARVEE cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	9.46	10.31	1.71	0.68	2.93	3.66	-0.21	-0.12
Cash from Investing Activity	-2.85	-3.08	-0.60	0.06	-1.26	-2.16	-1.32	0.50
Cash from Financing Activity	-4.92	-9.90	4.52	-6.06	-2.42	-0.19	-0.12	-0.16
Net Cash Flow	1.68	-2.67	5.63	-5.32	-0.75	1.31	-1.64	0.23
Free Cash Flow	7.96	8.02	-0.53	-1.68	1.47	1.07	-2.06	-2.95
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	158%	184%	44%	29%	64%	139%	10%	3%

ARVEE shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	73.50%	73.50%	73.50%	73.50%	73.50%	73.50%	73.50%	73.50%
Public	26.50%	26.50%	26.50%	26.50%	26.50%	26.50%	26.50%	26.50%
No. of Shareholders	1,623	1,576	1,505	1,505	1,861	1,638	1,596	1,947

ARVEE key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	52.66	52.40	60.70	109.78	72.94	73.48	79.66	121.05
Inventory Days	42.90	80.96	91.96	93.24	42.29	159.02	80.31	228.81
Days Payable	55.84	125.63	118.08	160.12	73.30	164.49	57.72	159.35
Cash Conversion Cycle	39.72	7.72	34.59	42.90	41.94	68.01	102.25	190.51
Working Capital Days	-6.52	10.29	-10.63	49.96	70.44	95.97	103.55	168.43
ROCE %	13.67%	14.90%	14.92%	12.89%	23.34%	6.83%	9.58%	7.53%

ARVEEUpdated 18 Oct 2026, 15:53

Arvee Laboratories I Ltd

ARVEEUpdated 18 Oct 2026, 15:53

Market Cap

₹249Cr.

Current Price

₹226

High / Low

₹291/129

Stock P/E

61.6

ROE7.32%

ROCE7.53%

Book Value₹30.7

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 2012, Arvee Laboratories India Ltd manufactures specialized chemicals[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	7.6	0.07	6.62	0.09	0.35	0.65	24.62	0.49	0.44
Sep 2023	8.91	0.08	8.22	0.09	0.42	0.28	25	0.21	0.19
Dec 2023	7.7	0.05	7.17	0.19	0.35	0.32	25	0.24	0.22
Mar 2024	6.14	0.05	5.35	0.21	0.37	0.58	81.03	0.12	0.11
Jun 2024	10.6	0.08	9.06	0.11	0.31	1.26	25.4	0.94	0.85
Sep 2024	12.53	0.05	11.03	0.16	0.3	1.31	25.19	0.98	0.89
Dec 2024	8.91	0.05	8.57	0.19	0.28	0.2	25	0.15	0.14
Mar 2025	6.45	0.07	6.23	0.21	0.27	0.09	22.22	0.07	0.06
Jun 2025	7.48	0.04	7.14	0.17	0.29	0.18	5.56	0.17	0.15
Sep 2025	3.45	0.04	3.33	0.23	0.3	0.01	0	0.01	0.01
Dec 2025	9.78	0.07	8.15	0.14	0.3	1.4	-30.71	1.83	1.66
Mar 2026	10.8	0.08	9.7	0.15	0.31	0.86	38.37	0.52	0.47
Jun 2026	17.23	0.06	14.74	0.18	0.32	2.29	26.2	1.69	1.53

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2016	26.82	3.07	21.83	0.1	1.49	0.53	66.04	0.19	0.23
Mar 2017	34.44	3.48	28.54	0.51	2.07	0.86	-81.4	1.55	1.91
Mar 2018	47.78	3.33	40.61	0.23	2.15	1.92	43.23	1.09	0.99
Mar 2019	54.9	1.63	48.73	0.35	2.35	2.54	11.02	2.26	2.05
Mar 2020	45.42	0.99	39.4	0.35	2.29	3.09	25.89	2.3	2.09
Mar 2021	47.38	0.58	41.31	0.56	2.41	3.64	26.37	2.68	2.43
Mar 2022	40.33	0.37	34.65	0.46	2.32	3.45	25.51	2.57	2.33
Mar 2023	61.35	0.39	54.06	1.35	2.08	6.17	33.23	4.12	3.74
Mar 2024	30.35	0.25	27.41	0.64	1.5	1.83	42.62	1.05	0.95
Mar 2025	38.49	0.25	34.88	0.66	1.15	2.87	25.09	2.15	1.95
Mar 2026	31.51	0.23	28.33	0.69	1.21	2.43	-3.7	2.53	2.3
TTM	41.26	0.25	35.92	0.7	1.23	4.56	—	4.05	3.67

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	73.5%
Public	26.5%

Shareholding trend

Ownership over time%

Quarter	Promoters	Public
Dec 2023	73.5%	26.5%
Mar 2024	73.5%	26.5%
Jun 2024	73.5%	26.5%
Sep 2024	73.5%	26.5%
Dec 2024	73.5%	26.5%
Mar 2025	73.5%	26.5%
Jun 2025	73.5%	26.5%
Sep 2025	73.5%	26.5%
Dec 2025	73.5%	26.5%
Mar 2026	73.5%	26.5%
Jun 2026	73.5%	26.5%
Sep 2026	73.5%	26.5%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2016	4.05	-1.41	25.32	7.25	35.21	13.15	4.3	0	17.76	35.21
Mar 2017	4.05	0.15	24.99	6.49	35.68	16.88	0	0	18.8	35.68
Mar 2018	5.51	8.69	16.15	13.77	44.12	14.88	1.18	0	28.06	44.12
Mar 2019	5.51	10.95	12.87	7.81	37.14	12.65	2.32	1.95	20.22	37.14
Mar 2020	5.51	13.25	3.87	11	33.63	13.18	1.78	3.09	15.58	33.63
Mar 2021	11.02	10.42	8.88	10.73	41.05	13.81	0.97	2.03	24.24	41.05
Mar 2022	11.02	12.92	3.13	11.61	38.68	13.84	0.98	0	23.86	38.68
Mar 2023	11.02	17.04	1	9.63	38.69	12.68	1.53	0	24.48	38.69
Mar 2024	11.02	18.09	1	8.45	38.56	12.67	2.62	0	23.27	38.56
Mar 2025	11.02	20.24	1.03	5.29	37.58	15.27	0.73	0	21.58	37.58
Mar 2026	11.02	22.77	1.11	7.99	42.89	16.72	0.9	1.7	23.57	42.89

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2016	—	—	—	—
Mar 2017	4.03	-1.4	-2.92	-0.29
Mar 2018	6.02	-1.23	-3.78	1
Mar 2019	9.46	-2.85	-4.92	1.68
Mar 2020	10.31	-3.08	-9.9	-2.67
Mar 2021	1.71	-0.6	4.52	5.63
Mar 2022	0.68	0.06	-6.06	-5.32
Mar 2023	2.93	-1.26	-2.42	-0.75
Mar 2024	3.66	-2.16	-0.19	1.31
Mar 2025	-0.21	-1.32	-0.12	-1.64
Mar 2026	-0.12	0.5	-0.16	0.23

Key ratios

Historical financial ratios

Category	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	82.61	87.12	118.25	52.66	52.40	60.70	109.78	72.94	73.48	79.66	121.05
Inventory Days	155.08	104.53	99.61	42.90	80.96	91.96	93.24	42.29	159.02	80.31	228.81
Days Payable	130.73	98.14	150.03	55.84	125.63	118.08	160.12	73.30	164.49	57.72	159.35
Cash Conversion Cycle	106.96	93.50	67.84	39.72	7.72	34.59	42.90	41.94	68.01	102.25	190.51
Working Capital Days	30.08	30.84	30.79	-6.52	10.29	-10.63	49.96	70.44	95.97	103.55	168.43
ROCE %	—	15.19%	17.64%	13.67%	14.90%	14.92%	12.89%	23.34%	6.83%	9.58%	7.53%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ARVEE LABORATORIES I LTD (ARVEE)?

The reported market capitalisation for ARVEE LABORATORIES I LTD (ARVEE) is ₹249Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of ARVEE?

The current price shown for ARVEE LABORATORIES I LTD (ARVEE) on Fincrux is ₹226 with a 52-week high/low of ₹291/129.

What is the P/E ratio of ARVEE LABORATORIES I LTD (ARVEE)?

The stock P/E for ARVEE LABORATORIES I LTD (ARVEE) is 61.6 on Fincrux, with ROE at 7.32% and ROCE at 7.53%.

What were ARVEE latest quarterly results?

For Jun 2026, ARVEE LABORATORIES I LTD (ARVEE) reported sales ₹17.23 Cr and net profit ₹1.69 Cr (figures in ₹ crore unless noted).

What are ARVEE annual sales and net profit?

For TTM, ARVEE LABORATORIES I LTD (ARVEE) shows sales of ₹41.26 Cr and net profit of ₹4.05 Cr on the Fincrux profit & loss statement.

Who owns ARVEE LABORATORIES I LTD (ARVEE)?

Latest shareholding for ARVEE LABORATORIES I LTD (ARVEE) on Fincrux: Promoters 73.50% (Sep 2026), Public 26.50% (Sep 2026), No. of Shareholders 1,947% (Sep 2026).

Where can I find ARVEE LABORATORIES I LTD (ARVEE) financials?

ARVEE LABORATORIES I LTD (ARVEE) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show ARVEE balance sheet and cash flow?

Yes. The ARVEE LABORATORIES I LTD (ARVEE) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 15:53